We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-14.21%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$89.1B
AUM Growth
+$88.9B
Cap. Flow
-$3.22B
Cap. Flow %
-3.61%
Top 10 Hldgs %
11.59%
Holding
2,672
New
86
Increased
706
Reduced
853
Closed
108

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$504M
2
AAPL icon
Apple
AAPL
+$433M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$248M
4
VTRS icon
Viatris
VTRS
+$241M
5
AMZN icon
Amazon
AMZN
+$210M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.43%
3 Financials 13.5%
4 Industrials 10.21%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSUR icon
2501
OraSure Technologies
OSUR
$273M
$2K ﹤0.01%
828
PTGX icon
2502
Protagonist Therapeutics
PTGX
$8.75B
$2K ﹤0.01%
307
RLMD icon
2503
Relmada Therapeutics
RLMD
$544M
$2K ﹤0.01%
116
SPWH icon
2504
Sportsman's Warehouse
SPWH
$43.7M
$2K ﹤0.01%
259
LYLT
2505
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$2K ﹤0.01%
557
INSG icon
2506
Inseego
INSG
$108M
$1K ﹤0.01%
66
LE icon
2507
Lands' End
LE
$361M
$1K ﹤0.01%
111
CMLS
2508
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$1K ﹤0.01%
+120
New +$1.41K
AAPL icon
2509
PUT
Apple
AAPL
$4.89T
-5,100
Closed -$891
ADTN icon
2510
Adtran
ADTN
$798M
-2,372
Closed -$44
AKBA icon
2511
Akebia Therapeutics
AKBA
$327M
-3,370
Closed -$2
ALGS icon
2512
Aligos Therapeutics
ALGS
$25.2M
-177
Closed -$9
ALLK
2513
DELISTED
Allakos
ALLK
-1,370
Closed -$8
AMCR icon
2514
CALL
Amcor
AMCR
$20.6B
-922
Closed -$52
AMCR icon
2515
PUT
Amcor
AMCR
$20.6B
-404
Closed -$23
APLT
2516
DELISTED
Applied Therapeutics
APLT
-393
Closed -$1
ATEC icon
2517
Alphatec Holdings
ATEC
$1.27B
-490,218
Closed -$5.64K
AXDX
2518
DELISTED
Accelerate Diagnostics
AXDX
-838
Closed -$12
AXGN icon
2519
Axogen
AXGN
$2.1B
-1,932
Closed -$15
BAK icon
2520
Braskem
BAK
$980M
-54,432
Closed -$925
BLUE
2521
DELISTED
bluebird bio
BLUE
-63
Closed -$6
CAE icon
2522
CAE Inc. Common Shares
CAE
$8.1B
-394,000
Closed -$10.3K
CIGI icon
2523
Colliers International
CIGI
$4.98B
-286
Closed -$37
CLOV icon
2524
Clover Health Investments
CLOV
$2.28B
-3,728
Closed -$13
CTRN icon
2525
Citi Trends
CTRN
$524M
-771
Closed -$24

Similar funds

Macquarie Group's Q2 2022 Portfolio in Review

As of Q2 2022, Macquarie Group held 2,672 positions worth $89.1B, up 67,641% from $131M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group withdrew a net $3.22B in Q2 2022, closing 108 positions and reducing 853 holdings. Its most notable exit was Healthcare Realty, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Petco worth $56.3M.

  • Macquarie Group's largest Q2 2022 buy was Petco: 3,818,489 shares worth $56.3M.
  • Macquarie Group added most to Hologic in Q2 2022, an estimated $324M increase.
  • Macquarie Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $504M.
  • Macquarie Group fully exited Healthcare Realty in Q2 2022, selling an estimated $10.8M.
  • Macquarie Group's ten largest holdings make up 12% of its $89.1B portfolio in Q2 2022.
  • Macquarie Group opened 86 new positions and closed 108 in Q2 2022.
  • Macquarie Group's portfolio value rose 67,641% quarter-over-quarter to $89.1B.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.